We are live on ! Find out more
IBIO icon

iBio
IBIO

10 hedge funds and large institutions have $393K invested in iBio in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0.01% more ownership

Funds ownership: 0% → 0.01% (+0.01%)

46% less capital invested

Capital invested by funds: $731K → $393K (-$338K)

50% less funds holding

Funds holding: 20 → 10 (-10)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 10

Holders
10
Holders Change
-10
Holders Change %
-50%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
2
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
S
SignatureFD
Georgia
+$208K
2
PAM
Panagora Asset Management
Massachusetts
+$19.7K
3
Northern Trust
Northern Trust
Illinois
+$11.3K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$28K
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$20K
3
UBS Group
UBS Group
Switzerland
-$12.9K
4
VF
Virtu Financial
New York
-$12K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$11K

IBIO Hedge Fund Activity: Q2 2018 in Review

10 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q2 2018, worth a combined $393K — down 46% from $731K a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of IBIO and 0 opened new positions — a net loss of 10 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was SignatureFD, adding an estimated $208K. The largest seller was Citadel Advisors, exiting entirely with an estimated $28K sold.

  • 10 institutional investors held iBio (IBIO) as of Q2 2018, down from 20 in Q1 2018.
  • Funds reported $393K of iBio stock for Q2 2018, down 46% quarter-over-quarter.
  • 0 funds opened new iBio positions in Q2 2018 and 10 closed out, a net change of -10 holders.
  • The largest iBio buyer in Q2 2018 was SignatureFD, an estimated $208K added.
  • The largest iBio seller in Q2 2018 was Citadel Advisors, an estimated $28K sold.

Based on aggregated 13F filings for Q2 2018.